Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Currently submitted to: JMIR Public Health and Surveillance

Date Submitted: Nov 7, 2020
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Clinical characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil

  • Daniele Melo Sardinha; 
  • Karla Valéria Batista Lima; 
  • Ana Lúcia Da Silva Ferreira; 
  • Juliana Conceição Dias Garcez; 
  • Thalyta Mariany Rêgo Lopes Ueno; 
  • Yan Corrêa Rodrigues; 
  • Anderson Lineu Siqueira Dos Santos; 
  • Rosane Do Socorro Pompeu Loiola; 
  • Ricardo José De Paula Souza E Guimaraes; 
  • Luana Nepomuceno Gondim Costa Lima

ABSTRACT

Background:

The indigenous people of Brazil present several cases and deaths, affecting 158 peoples, with high vulnerability and limited access to health services.

Objective:

Investigate the clinical characteristics of severe acute respiratory syndrome by COVID-19 in indigenous peoples of Brazil.

Methods:

The epidemiological, cross-sectional and analytical study, from the data of the platform opendataSUS referring to the SIVEP-GRIPE in the period of 01/01/2020 until 31/08/2020. Profile variables, signs and symptoms, and risk factors/comorbidities. The data were analyzed by Bioestat 5.3.

Results:

1,207 cases and 470 deaths. Profile: male gender (59.48%) mean age 53. Signs and symptoms: fever (74.23%), cough (77.71%), sore throat (35.62%), dyspnea (69.34%), respiratory discomfort (62.80%), O2 saturation <95% (56.42%); and associated with mortality: dyspnea (80.0%) and O2 saturation <95% (69.36%). Risk factors and comorbidities (45.89%) were associated with deaths (54.04%). Comorbidities: Chronic Cardiovascular Disease (18.97%) and Diabetes Mellitus (18.97%), and associated with deaths: Chronic Cardiovascular Disease (24.46%). There was significance in the survivors vaccinated for influenza (26.18%).

Conclusions:

The public and health policies of Brazil should be directed to control the dissemination of COVID-19 in this population, that COVID-19 evolves in the same intensity, however, the indigenous have vulnerabilities that can enhance the impact of the pandemic in this population.


 Citation

Please cite as:

Sardinha DM, Lima KVB, Ferreira ALDS, Garcez JCD, Ueno TMRL, Rodrigues YC, Santos ALSD, Loiola RDSP, Guimaraes RJDPSE, Lima LNGC

Clinical characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil

JMIR Preprints. 07/11/2020:25346

URL: https://preprints.jmir.org/preprint/25346

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.